Monsanto Co. (NYSE:MON) EVP Steven Mizell sold 310 shares of the company’s stock in a transaction that occurred on Monday, October 10th. The shares were sold at an average price of $103.09, for a total value of $31,957.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Monsanto Co. (NYSE:MON) opened at 102.11 on Monday. Monsanto Co. has a 1-year low of $83.73 and a 1-year high of $114.26. The company has a 50-day moving average price of $104.39 and a 200 day moving average price of $101.78. The firm has a market capitalization of $44.69 billion, a P/E ratio of 34.17 and a beta of 1.19.
Monsanto (NYSE:MON) last released its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of ($0.02) by $0.09. The company had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The firm’s revenue was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.19) earnings per share. Analysts expect that Monsanto Co. will post $4.89 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be issued a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.12%. The ex-dividend date of this dividend is Wednesday, October 5th. Monsanto’s payout ratio is currently 71.05%.
A number of equities research analysts recently commented on MON shares. Goldman Sachs Group Inc. set a $92.00 target price on Monsanto and gave the company a “sell” rating in a research report on Monday, June 27th. Vetr upgraded Monsanto from a “buy” rating to a “strong-buy” rating and set a $116.55 target price on the stock in a research report on Monday, June 27th. Jefferies Group reiterated a “buy” rating on shares of Monsanto in a research report on Wednesday, June 29th. Deutsche Bank AG reiterated a “buy” rating and issued a $118.00 target price on shares of Monsanto in a research report on Thursday, June 30th. Finally, Piper Jaffray Cos. dropped their target price on Monsanto from $127.00 to $118.00 and set an “overweight” rating on the stock in a research report on Thursday, June 30th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $114.65.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Charter Trust Co. raised its position in Monsanto by 0.6% in the third quarter. Charter Trust Co. now owns 10,605 shares of the company’s stock worth $1,084,000 after buying an additional 65 shares during the last quarter. Pennsylvania Trust Co raised its position in Monsanto by 0.8% in the third quarter. Pennsylvania Trust Co now owns 7,355 shares of the company’s stock worth $752,000 after buying an additional 55 shares during the last quarter. Callahan Advisors LLC raised its position in Monsanto by 77.9% in the third quarter. Callahan Advisors LLC now owns 15,209 shares of the company’s stock worth $1,554,000 after buying an additional 6,662 shares during the last quarter. National Pension Service raised its position in Monsanto by 8.6% in the third quarter. National Pension Service now owns 287,008 shares of the company’s stock worth $29,332,000 after buying an additional 22,777 shares during the last quarter. Finally, Private Trust Co. NA raised its position in Monsanto by 2.5% in the third quarter. Private Trust Co. NA now owns 8,737 shares of the company’s stock worth $892,000 after buying an additional 216 shares during the last quarter. 78.94% of the stock is currently owned by institutional investors and hedge funds.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.